⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SION News
Sionna Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
SION
Sionna Therapeutics Reports First Quarter 2026 Financial Results
globenewswire.com
SION
Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in Participants with Cystic Fibrosis
globenewswire.com
SION
SION POWER TARGETS DRONE WARFARE GAP WITH 500 WH/KG LITHIUM-METAL BATTERIES
prnewswire.com
SION
Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium
globenewswire.com
SION
Form 8-K
sec.gov
SION
Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
SION
Sionna Therapeutics to Participate in Upcoming March 2026 Investor Conferences
globenewswire.com
SION
Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026
globenewswire.com
SION
Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
SION